QuickView for U5 snRNP (biogroup)

1. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

1. Structure of the human 20S U5 snRNP.
2. Structural basis of human U5 snRNP late biogenesis and recycling.
3. TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation.
4. Mechanism for Aar2p function as a U5 snRNP assembly factor.
5. DHX15-independent roles for TFIP11 in U6 snRNA modification, U4/U6.U5 tri-snRNP assembly and pre-mRN…

There were no clinical trials for U5 snRNP